Search results for: Bernarda Zamora
Filter search results
Quality of Life and Rare Disease: Lessons from Spinal Muscular Atrophy
2 April 2019
…RePEc. Berdud, M., Drummond, M.F., and Towse, A., 2018. Establishing a Reasonable Price for an Orphan Drug. OHE Research Paper. RePEc. Zamora, B., Maignen, F., O’Neill, P., Mestre-Ferrandiz, J. and…
MoCA Initiative and its Value Framework: An Opportunity to Improve Decision Making for Orphan Drugs in Europe?
18 September 2018
…product will reach the market at all. Towse, A. and Garau, M. (2018). Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. OHE Consulting Report. RePEc Zamora, B.,…
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
…Economics. RePEc. Towse, A., Cole, A. and Zamora, B., 2018. The Debate on Indication-Based Pricing in the US and Five Major European Countries. OHE Consulting Report. London: Office of Health…
OHE at the ISPOR Summit on New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare October, 2018
5 November 2018
…to the “Affordability Issue”. Value in Health, 21(3), pp.76-279. DOI: https://doi.org/10.1016/j.jval.2017.12.013. Towse, A., Cole, A., and Zamora, B. (2018). The Debate on Indication-Based Pricing in the U.S. and Five…